Browsing by Author "Zima, Endre (7003913627)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication COOL AMI EU pilot trial: A multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction(2017) ;Noc, Marko (7004055753) ;Erlinge, David (7005319185) ;Neskovic, Aleksandar N. (35597744900) ;Kafedzic, Srdjan (55246101300) ;Merkely, Béla (7004434435) ;Zima, Endre (7003913627) ;Fister, Misa (13105598500) ;Petrović, Milovan (16234216100) ;Čanković, Milenko (57204401342) ;Veress, Gábor (59099028800) ;Laanmets, Peep (55345333500) ;Pern, Teele (57195330004) ;Vukcevic, Vladan (15741934700) ;Dedovic, Vladimir (55959310400) ;Średniawa, Beata (57197282694) ;Światkowski, Andrzej (57204007408) ;Keeble, Thomas R. (20334838200) ;Davies, John R. (56939639900) ;Warenits, Alexandra-Maria (55317914100) ;Olivecrona, Göran (8656313100) ;Peruga, Jan Zbigniew (6603426226) ;Ciszewski, Michal (6602484219) ;Horvath, Ivan (35315794200) ;Edes, Istvan (7003689191) ;Nagy, Gergely Gyorgy (57195331558) ;Aradi, Daniel (22984252200)Holzer, Michael (15740955800)Aims: We aimed to investigate the rapid induction of therapeutic hypothermia using the ZOLL Proteus Intravascular Temperature Management System in patients with anterior ST-elevation myocardial infarction (STEMI) without cardiac arrest. Methods and results: A total of 50 patients were randomised; 22 patients (88%; 95% confidence interval [CI]: 69-97%) in the hypothermia group and 23 patients (92%; 95% CI: 74-99) in the control group completed cardiac magnetic resonance imaging at four to six days and 30-day follow-up. Intravascular temperature at coronary guidewire crossing after 20.5 minutes of endovascular cooling decreased to 33.6°C (range 31.9-35.5°C). There was a 17-minute (95% CI: 4.6-29.8 min) cooling-related delay to reperfusion. In "per protocol" analysis, median infarct size/left ventricular mass was 16.7% in the hypothermia group versus 23.8% in the control group (absolute reduction 7.1%, relative reduction 30%; p=0.31) and median left ventricular ejection fraction (LVEF) was 42% in the hypothermia group and 40% in the control group (absolute reduction 2.4%, relative reduction 6%; p=0.36). Except for self-terminating paroxysmal atrial fibrillation (32% versus 8%; p=0.074), there was no excess of adverse events in the hypothermia group. Conclusions: We rapidly and safely cooled patients with anterior STEMI to 33.6°C at the time of coronary guidewire crossing. This is ≥1.1°C lower than in previous cooling studies. Except for self-terminating atrial fibrillation, there was no excess of adverse events and no clinically important cooling-related delay to reperfusion. A statistically non-significant numerical 7.1% absolute and 30% relative reduction in infarct size warrants a pivotal trial powered for efficacy. © Europa Digital & Publishing 2017. All rights reserved.
